Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Interlink Electronics
LINK
$80.3M
| $112K | ﹤0.01% |
46,191
-3,561
| -7% | -$9.48K |
|
4077
Dragonfly Energy
DFLI
$18.9M
| $111K | ﹤0.01% |
2,332
+765
| +49% | +$45.7K |
|
4078
Mediaco Holding
MDIA
$78M
| $111K | ﹤0.01% |
86,633
-138,843
| -62% | -$445K |
|
4079
Jaguar Health
JAGX
$4.67M
| $110K | ﹤0.01% |
103
+64
| +164% | +$92.8K |
|
4080
Aprea Therapeutics
APRE
$7.83M
| $110K | ﹤0.01% |
40,067
+4,394
| +12% | +$15.5K |
|
|
ISPO
4081
DELISTED
Inspirato
ISPO
| $110K | ﹤0.01% |
27,169
+12,918
| +91% | +$53.5K |
|
4082
Cineverse
CNVS
$65.6M
| $110K | ﹤0.01% |
112,304
+7,515
| +7% | +$6.26K |
|
|
BNAI
4083
Brand Engagement Network
BNAI
$95.3M
| $108K | ﹤0.01% |
10,379
-1,604
| -13% | -$31.1K |
|
4084
PodcastOne
PODC
$104M
| $108K | ﹤0.01% |
70,518
+21,562
| +44% | +$32.8K |
|
4085
AtaiBeckley Inc
ATAI
$2.68B
| $107K | ﹤0.01% |
92,619
-24,607
| -21% | -$32.8K |
|
4086
XBP Global Holdings
XBP
$36.4M
| $107K | ﹤0.01% |
9,957
+463
| +5% | +$6.01K |
|
4087
Shimmick
SHIM
$181M
| $106K | ﹤0.01% |
43,075
+2,537
| +6% | +$7.33K |
|
|
JCTC
4088
Jewett-Cameron Trading
JCTC
$11.1M
| $106K | ﹤0.01% |
21,337
+632
| +3% | +$2.85K |
|
4089
AYTU BioPharma
AYTU
$25.3M
| $106K | ﹤0.01% |
45,102
+9,183
| +26% | +$23.8K |
|
|
AGIG
4090
Abundia Global Impact Group
AGIG
$36.5M
| $105K | ﹤0.01% |
9,535
-98
| -1% | -$1.15K |
|
|
AXIL
4091
AXIL Brands
AXIL
$40M
| $104K | ﹤0.01% |
24,267
+8,768
| +57% | +$48.7K |
|
|
CRDL
4092
Cardiol Therapeutics
CRDL
$164M
| $104K | ﹤0.01% |
52,435
| – | – |
|
4093
Enveric Biosciences
ENVB
$6.24M
| $103K | ﹤0.01% |
1,211
+963
| +388% | +$88.6K |
|
|
MTVA
4094
MetaVia Inc
MTVA
$7.69M
| $103K | ﹤0.01% |
2,961
+864
| +41% | +$36.9K |
|
4095
Bullfrog AI
BFRG
$10.9M
| $103K | ﹤0.01% |
35,953
+8,221
| +30% | +$20.7K |
|
4096
BTCS Inc
BTCS
$55.3M
| $103K | ﹤0.01% |
88,615
-3,589
| -4% | -$4.72K |
|
4097
Spectral AI
MDAI
$55.7M
| $103K | ﹤0.01% |
96,738
+29,527
| +44% | +$45.2K |
|
|
KNDI
4098
Kandi Technologies Group
KNDI
$65.5M
| $102K | ﹤0.01% |
49,661
+5,026
| +11% | +$9.14K |
|
4099
Sidus Space
SIDU
$229M
| $102K | ﹤0.01% |
36,370
+5,688
| +19% | +$15.6K |
|
4100
PAVmed
PAVM
$33.9M
| $101K | ﹤0.01% |
2,750
+296
| +12% | +$9.08K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.